REICH KRISTIAN (Chief Scientific Officer) sold 202.91K shares of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $3.01M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/10/2025ACC: 0001213900-25-120105
Officer· Chief Scientific Officer
Since Apr 2022
-202.91K
Net shares
Net seller
$3.01M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
202.91K disposed
Non-Derivative Transactions2
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−130K
Price / share
$15.08
Trade value
$1.96M
% of position
64.1%
12/8/2025
202.91K→72.91K
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−72.91K
Price / share
$14.43
Trade value
$1.05M
% of position
New position
12/9/2025
72.91K→0.00
Total
Net shares
−202.91K
Net value
-$3.01M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Direct | 12/8/2025 | S · Sale | −130K | $15.08 | $1.96M | 64.1% | 202.91K | 72.91K |
| Class A ordinary shares, par value $0.0001 per share Direct | 12/9/2025 | S · Sale | −72.91K | $14.43 | $1.05M | New position | 72.91K | 0.00 |
| Total | −202.91K | -$3.01M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A ordinary shares, par value $0.0001 per share
IndirectShares owned2.97M
Total
2.97M indirect2.97M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A ordinary shares, par value $0.0001 per share | 2.97M | Indirect |
| Total | 2.97M | 2.97M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported